The pharmacology of Parkinson's disease: l-dopa and beyond
- 31 December 1984
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 5, 25-27
- https://doi.org/10.1016/0165-6147(84)90355-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Adjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085Zeitschrift für Neurologie, 1982
- Behavioural and biochemical changes following chronic administration of L-DOPA to ratsEuropean Journal of Pharmacology, 1982
- Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptidesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Biopterin in human brain and urine from controls and parkinsonian patients: Application of a new radioimmunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Dopamine-stimulated adenylate cyclase activity in the human brain: Changes in ParkinsonismBiochemical Medicine, 1978
- Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brainEuropean Journal of Pharmacology, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-AkineseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1962
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960